kadsurenone

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2013
051019852013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
During inflammation polymorphonuclear cells (PMNs) are exposed to agonistic stimuli including activated complement, kallikrein… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
1987
1987
WEB 2086, a thieno-triazolodiazepine, is a potent and specific antagonist of platelet activating factor (PAF) in vitro and in… (More)
Is this relevant?
1987
1987
Platelet-activating factor (PAF) is a potent mediator of anaphylaxis and shock. In addition, evidence for PAF participation in… (More)
Is this relevant?
1987
1987
We treated four anesthetized dogs (Canis familiaris) with the platelet activating factor (PAF) receptor antagonist kadsurenone… (More)
Is this relevant?
1986
1986
The effects of the antagonist kadsurenone on the platelet activating factor (Paf)-induced chemiluminescence of guinea-pig… (More)
Is this relevant?
1986
1986
BN 52021 is a chemically defined substance extracted from Ginkgo biloba leaves. Its inhibitory potency was tested on washed human… (More)
Is this relevant?
1986
1986
The ECG and haemodynamic alterations caused by the i.v. infusion of platelet-activating factor (PAF) in the rabbit were studied… (More)
Is this relevant?
1986
1986
Platelet activating factor (PAF), a potent lipid-like vasoactive agent, induced rat foot edema when it was injected subplantarly… (More)
Is this relevant?
1985
1985
Evidence from three types of experiments indicates that platelet activating factor (PAF)1 is an important mediator of endotoxin… (More)
Is this relevant?
1985
1985
Platelet-activating factor (PAF) is a potent lipid mediator of inflammation and asthma. Using a receptor preparation of rabbit… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 6
  • figure 4
Is this relevant?